银屑病-话题@MedSci

#银屑病#

57篇内容 | 4472人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=913939, encodeId=956f9139398d, content=<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>PF-06826647展现出了优于传统口服治疗银屑病方法的疗效和安全性。, objectTitle=Lancet Rheumatol：TYK2抑制剂PF-06826647治疗银屑病的疗效和安全性, objectType=article, longId=205276, objectId=378a2052e6cd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202113/1609655503797_2110107.jpg, objectUrl=/article/show_article.do?id=378a2052e6cd, replyNumber=0, likeNumber=182, createdTime=2021-01-05, rootId=0, userName=Nebula-Qin, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=378a2052e6cd, moduleTitle=Lancet Rheumatol：TYK2抑制剂PF-06826647治疗银屑病的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=378a2052e6cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=897946, encodeId=e46589e94658, content=<a href='/topic/show?id=5cc96e515a9' target=_blank style='color:#2F92EE;'>#牙周炎#</a>与<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>存在某种关联, objectTitle=J Clin Periodontol：有效的牙周治疗可以改善银屑病患者的全身状况, objectType=article, longId=203173, objectId=58f62031e335, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/131.jpg, objectUrl=/article/show_article.do?id=58f62031e335, replyNumber=0, likeNumber=247, createdTime=2020-11-09, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58f62031e335, moduleTitle=J Clin Periodontol：有效的牙周治疗可以改善银屑病患者的全身状况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58f62031e335)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=896229, encodeId=d49f8962297e, content=中度至重度<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>, 在治疗第16周时，<a href='/topic/show?id=4f363411d4' target=_blank style='color:#2F92EE;'>#bimekizumab#</a>治疗后患者中有86.2％皮肤达到几乎无皮损（PASI 90），这个是极其惊人的，而且是中重度哦！！, objectTitle=头对头3期临床证实：抗IL-17单抗Bimekizumab治疗中度至重度银屑病优于TNF单抗修美乐, objectType=article, longId=202790, objectId=00a7202e904b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-suggesting-hospital-program-to-patient-P9AB784.jpg, objectUrl=/article/show_article.do?id=00a7202e904b, replyNumber=0, likeNumber=200, createdTime=2020-11-02, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00a7202e904b, moduleTitle=头对头3期临床证实：抗IL-17单抗Bimekizumab治疗中度至重度银屑病优于TNF单抗修美乐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00a7202e904b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=896216, encodeId=02db8962165a, content=<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>IL-17单抗应该更优化的, objectTitle=头对头3期临床证实：抗IL-17单抗Bimekizumab治疗中度至重度银屑病优于TNF单抗修美乐, objectType=article, longId=202790, objectId=00a7202e904b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-suggesting-hospital-program-to-patient-P9AB784.jpg, objectUrl=/article/show_article.do?id=00a7202e904b, replyNumber=0, likeNumber=185, createdTime=2020-11-02, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00a7202e904b, moduleTitle=头对头3期临床证实：抗IL-17单抗Bimekizumab治疗中度至重度银屑病优于TNF单抗修美乐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00a7202e904b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=885156, encodeId=e58b88515668, content=<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>的<a href='/topic/show?id=b086512e33c' target=_blank style='color:#2F92EE;'>#心肌梗死#</a>患者院内死亡率较低，这可能是由于年龄较小所致。, objectTitle=JAHA：银屑病对心肌梗死患者死亡率和结局的影响, objectType=article, longId=200666, objectId=825820066628, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020914/1600058384162_1739456.jpg, objectUrl=/article/show_article.do?id=825820066628, replyNumber=0, likeNumber=206, createdTime=2020-09-14, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=825820066628, moduleTitle=JAHA：银屑病对心肌梗死患者死亡率和结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=825820066628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=811847, encodeId=1d4581184e38, content=<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>、<a href='/topic/show?id=5a64966325c' target=_blank style='color:#2F92EE;'>#银屑病关节炎#</a>与<a href='/topic/show?id=e59810186916' target=_blank style='color:#2F92EE;'>#骨质疏松症#</a>之间的关系，背后是不是<a href='/topic/show?id=5b0fe906618' target=_blank style='color:#2F92EE;'>#维生素D#</a>（VitD3）在起作用？它既有免疫调节作用，也有促进钙吸收的作用, objectTitle=Ann Rheum Dis：银屑病、银屑病关节炎与骨质疏松症之间的关系, objectType=article, longId=199794, objectId=00fa199e94bc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020821/1597995438080_1613704.jpg, objectUrl=/article/show_article.do?id=00fa199e94bc, replyNumber=1, likeNumber=419, createdTime=2020-08-21, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00fa199e94bc, moduleTitle=Ann Rheum Dis：银屑病、银屑病关节炎与骨质疏松症之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00fa199e94bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803263, encodeId=e4a98032635d, content=<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>重磅药物之间的头对头的研究，现在开始了。, objectTitle=牛皮癣III期临床：礼来的IL-23单抗mirikizumab优于诺华的IL-17A单抗Cosentyx, objectType=article, longId=197732, objectId=5be919e73267, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200716/378cc99849454adbb80b3e84224ef4f9.jpg, objectUrl=/article/show_article.do?id=5be919e73267, replyNumber=0, likeNumber=167, createdTime=2020-07-19, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5be919e73267, moduleTitle=牛皮癣III期临床：礼来的IL-23单抗mirikizumab优于诺华的IL-17A单抗Cosentyx, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5be919e73267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803027, encodeId=8cd680302e0f, content=<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>特立硼罗同样的机制, objectTitle=NEJM：罗氟司特乳膏局部治疗可显著改善银屑病患者皮肤症状, objectType=article, longId=197644, objectId=031019e644e6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020716/1594898022818_2051781.jpg, objectUrl=/article/show_article.do?id=031019e644e6, replyNumber=0, likeNumber=177, createdTime=2020-07-16, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=031019e644e6, moduleTitle=NEJM：罗氟司特乳膏局部治疗可显著改善银屑病患者皮肤症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=031019e644e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=801951, encodeId=4fe08019513e, content=<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>白介素36，关注少, objectTitle=泛发性脓疱型银屑病：Imsidolimab获FDA孤儿药称号, objectType=article, longId=197298, objectId=6b4219e29846, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202079/1594298546291_5295902.jpeg, objectUrl=/article/show_article.do?id=6b4219e29846, replyNumber=0, likeNumber=184, createdTime=2020-07-09, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b4219e29846, moduleTitle=泛发性脓疱型银屑病：Imsidolimab获FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b4219e29846)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601718, encodeId=6f96601e182f, content=<a href='/topic/show?id=d4d196630b4' target=_blank style='color:#2F92EE;'>#银屑病#</a>东亚地区银屑病患病率为0.14%，中国约200万病人😂😂, objectTitle=BMJ：全球银屑病负担研究, objectType=article, longId=195188, objectId=9982195188f1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202062/1591097637176_2051781.jpg, objectUrl=/article/show_article.do?id=9982195188f1, replyNumber=0, likeNumber=181, createdTime=2020-06-07, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9982195188f1, moduleTitle=BMJ：全球银屑病负担研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9982195188f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

让牛皮癣彻底干净！

2020-05-29

Nebula-Qin (审核中...)

前往app查看评论内容

#银屑病#PF-06826647展现出了优于传统口服治疗银屑病方法的疗效和安全性。

Lancet Rheumatol：TYK2抑制剂PF-06826647治疗银屑病的疗效和安全性

2021-01-05

lovetcm (审核中...)

前往app查看评论内容

#牙周炎#与#银屑病#存在某种关联

J Clin Periodontol：有效的牙周治疗可以改善银屑病患者的全身状况

2020-11-09

爆笑小医 (审核中...)

前往app查看评论内容

中度至重度#银屑病#, 在治疗第16周时，#bimekizumab#治疗后患者中有86.2％皮肤达到几乎无皮损（PASI 90），这个是极其惊人的，而且是中重度哦！！

头对头3期临床证实：抗IL-17单抗Bimekizumab治疗中度至重度银屑病优于TNF单抗修美乐

2020-11-02

lovetcm (审核中...)

前往app查看评论内容

#银屑病#IL-17单抗应该更优化的

头对头3期临床证实：抗IL-17单抗Bimekizumab治疗中度至重度银屑病优于TNF单抗修美乐

2020-11-02

lovetcm (审核中...)

前往app查看评论内容

#银屑病#的#心肌梗死#患者院内死亡率较低，这可能是由于年龄较小所致。

JAHA：银屑病对心肌梗死患者死亡率和结局的影响

2020-09-14

lovetcm (审核中...)

前往app查看评论内容

#银屑病#、#银屑病关节炎#与#骨质疏松症#之间的关系，背后是不是#维生素D#（VitD3）在起作用？它既有免疫调节作用，也有促进钙吸收的作用

Ann Rheum Dis：银屑病、银屑病关节炎与骨质疏松症之间的关系

2020-08-21

lovetcm (审核中...)

前往app查看评论内容

#银屑病#重磅药物之间的头对头的研究，现在开始了。

牛皮癣III期临床：礼来的IL-23单抗mirikizumab优于诺华的IL-17A单抗Cosentyx

2020-07-19

lovetcm (审核中...)

前往app查看评论内容

#银屑病#特立硼罗同样的机制

NEJM：罗氟司特乳膏局部治疗可显著改善银屑病患者皮肤症状

2020-07-16

lovetcm (审核中...)

前往app查看评论内容

#银屑病#白介素36，关注少

泛发性脓疱型银屑病：Imsidolimab获FDA孤儿药称号

2020-07-09

lovetcm (审核中...)

前往app查看评论内容

#银屑病#东亚地区银屑病患病率为0.14%，中国约200万病人😂😂

BMJ：全球银屑病负担研究

2020-06-07

科室
- - 订阅+
  - 更多科室
工具
服务